![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human liver shows absence of immunoreactivity (negative control).](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0007.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human liver shows absence of immunoreactivity (negative control).")
| Reactivity | HuSpecies Glossary |
| Applications | WB, IHC |
| Clone | CL1679 |
| Clonality | Monoclonal |
| Host | Mouse |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Description | Novus Biologicals Mouse ASRGL1 Antibody (CL1679) - BSA Free (NBP2-42378) is a monoclonal antibody validated for use in IHC and WB. All Novus Biologicals antibodies are covered by our 100% guarantee. |
| Immunogen | This antibody was developed using a recombinant protein derived from Q7L266, with the exact immunogen sequence remaining proprietary. |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Host | Mouse |
| Gene | ASRGL1 |
| Purity | Protein A purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | For IHC-Paraffin, HIER pH 6 retrieval is recommended. |
||
| Control Peptide |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.2) and 40% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Purity | Protein A purified |
![Immunohistochemistry PTH Antibody (918462) [Unconjugated]](https://images.novusbio.com/images2/PTH_MAB7665_Immunohistochemistry_16650.jpg)
![Western Blot PTH Antibody (918462) [Unconjugated]](https://images.novusbio.com/images2/PTH_MAB7665_Western_Blot_16656.jpg)
![Simple Western Albumin Antibody (188835) [Unconjugated] - Serum](https://images.novusbio.com/images2/Albumin_MAB1455_Simple_Western_21888.jpg)
![Immunocytochemistry Albumin Antibody (188835) [Unconjugated] - Serum](https://images.novusbio.com/images2/Albumin_MAB1455_Immunocytochemistry__Immunofluorescence_17777.jpg)
![Immunohistochemistry Albumin Antibody (188835) [Unconjugated] - Serum](https://images.novusbio.com/images2/Albumin_MAB1455_Immunohistochemistry_23317.jpg)
![Immunocytochemistry TNF-alpha Antibody [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_AF-410-NA_Immunocytochemistry_7296.jpg)
![Neutralization TNF-alpha Antibody [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_AF-410-NA_Block_Neutralize_8706.jpg)
![Immunocytochemistry TNF-alpha Antibody [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_AF-410-NA_Immunocytochemistry_9636.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for ASRGL1 Antibody (NBP2-42378)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human endometrial cancer shows strong immunoreactivity in tumor cells.](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0002.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human endometrial cancer shows strong immunoreactivity in tumor cells.")
![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human ovarian cancer shows moderate to strong positivity in tumor cells.](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0003.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human ovarian cancer shows moderate to strong positivity in tumor cells.")
![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human endometrium shows strong immunoreactivity in glandular cells.](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0004.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human endometrium shows strong immunoreactivity in glandular cells.")
![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human fallopian tube shows strong immunoreactivity in glandular epithelium cells.](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0005.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human fallopian tube shows strong immunoreactivity in glandular epithelium cells.")
![Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human colorectal cancer shows absence of positivity in tumor cells (negative control).](http://images.novusbio.com/fullsize/ASRGL1-Antibody-CL1679-Immunohistochemistry-NBP2-42378-img0006.jpg "Immunohistochemistry: ASRGL1 Antibody (CL1679) [NBP2-42378] - Staining of human colorectal cancer shows absence of positivity in tumor cells (negative control).")
![Western Blot Catalase Antibody [Unconjugated]](https://images.novusbio.com/images2/Catalase_AF3398_Western_Blot_5287.jpg)
![Simple Western Catalase Antibody [Unconjugated]](https://images.novusbio.com/images2/Catalase_AF3398_Simple_Western_16990.jpg)
![Knockout Validated Catalase Antibody [Unconjugated]](https://images.novusbio.com/images2/Catalase_AF3398_Knockout_Validated_24032.jpg)
![Bioactivity IBSP/Sialoprotein II [Unconjugated]](https://images.novusbio.com/images/4014-sp_recombinant-human-ibsp-sialoprotein-ii-protein-cf-bioactivity-4420249391..jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")